HIV disease progression: depression, stress, and possible mechanisms.
about
A randomized, double-blind, placebo-controlled trial of Lessertia frutescens in healthy adultsWhy the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject DrugsAnxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literatureConsumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled TrialFrequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS)Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future DirectionsPrevalence of shingles and its association with PTSD among HIV-infected women in Rwanda'Multimorbidity' as the manifestation of network disturbances.Sexual violence and HIV transmission: summary proceedings of a scientific research planning meeting.Greentree white paper: sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practice.Living in rural New England amplifies the risk of depression in patients with HIV.Stress biomarkers as outcomes for HIV+ prevention: participation, feasibility and findings among HIV+ Latina and African American mothers.Components of depression in HIV-1 infection: their differential relationship to neurocognitive performance.Validation of brief screening tools for depressive and alcohol use disorders among TB and HIV patients in primary care in Zambia.Time to depression treatment in primary care among HIV-infected and uninfected veteransPrevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient populationNeurokinin-1 receptor (NK1-R) expression in the brains of SIV-infected rhesus macaques: implications for substance P in NK1-R immune cell trafficking into the CNSPopulation levels of psychological stress, herpesvirus reactivation and HIV.The Translation and Cultural Adaptation of Patient-reported Outcome Measures for a Clinical Study Involving Traditional Health Providers and Bio-medically Trained PractitionersPerceived stress and norepinephrine predict the effectiveness of response to protease inhibitors in HIV.Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: proactive behavior, avoidant coping, and depressionStress and poverty predictors of treatment adherence among people with low-literacy living with HIV/AIDS.Symptoms of common mental disorder and cognitive associations with seropositivity among a cohort of people coming for testing for HIV/AIDS in Goa, India: a cross-sectional survey.Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS.Prevalence and correlates of depressive symptoms in HIV-positive patients: a cross-sectional study among newly diagnosed patients in Yaoundé, Cameroon.Human immunodeficiency virus and depression in primary care: a clinical review.Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection.Mental health and support among young key populations: an ecological approach to understanding and intervention.Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.HIV stigma and physical health symptoms: do social support, adaptive coping, and/or identity centrality act as resilience resources?The impact of prolonged exposure on PTSD symptoms and associated psychopathology in people living with HIV: a randomized test of concept.Depression in HIV infected patients: a review.A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIVNeuropsychiatric complications of aging with HIV.Psychometric validation of the BDI-II among HIV-positive CHARTER study participants.Psychosocial and Neurohormonal Predictors of HIV Disease Progression (CD4 Cells and Viral Load): A 4 Year Prospective StudyLongitudinal association of alcohol use with HIV disease progression and psychological health of women with HIVValidation of Six Short and Ultra-short Screening Instruments for Depression for People Living with HIV in Ontario: Results from the Ontario HIV Treatment Network Cohort StudyCognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trialRandomized controlled trial of mindfulness-based stress reduction delivered to human immunodeficiency virus-positive patients in Iran: effects on CD4⁺ T lymphocyte count and medical and psychological symptoms
P2860
Q21092506-605ED099-B425-4A6C-B854-DE27CF60C389Q21284788-79D0BE34-9A2A-4401-A235-544BBF695F62Q28397433-3F94F8DD-9A50-41C1-8106-B4B9DFE7F2DEQ28546632-0BD2AB0D-FF19-467F-B728-2967C079CE20Q28550440-480A1B76-3485-4312-BBB4-766C94475E87Q30244921-FA760647-2E26-4E10-97A8-AA75EC157397Q30389270-AA4A357C-9F3E-4788-A558-9BE2F5BF10ECQ30390588-F1D26F4C-7026-40E7-AB96-EFED7C59FB7FQ30414954-DAAA92B4-1256-4CFB-9531-E407961B8892Q30416473-436513B1-6B97-491B-8F9F-81328827CFF4Q33415356-5D119567-5287-4803-B0FD-9BE8DC85FA39Q33712104-B1D400AA-FCEC-4BEE-90DA-55B26A7B6116Q33827642-47CBF78B-8C62-451B-B28F-537AFC3EEDF0Q33890003-8630612A-8EA8-4460-9B6C-54D8372030E2Q33898667-AC9C0DF0-7D0E-474B-B35F-E9628D662F89Q33978708-E16B5E20-F967-4658-BA47-1120B0E7930DQ34086928-2EDAD6EA-F49D-4830-8FFF-2697352C2722Q34141187-9B5C0643-A616-41F2-AEEE-4D7783AE6083Q34314209-5E59AA3B-2DEC-42F7-839F-57ED8EF3C104Q34400028-D8A17B21-6327-48C4-BA81-04708B442DCBQ34400036-3B96C2A3-E62C-4518-AB57-19E30FD0BFAFQ34468878-19E4F7F8-5C84-4050-ADA3-897EC8395605Q34623219-C97596A7-435F-4EDC-90E3-A63D4774431BQ34845860-8DE5DDF3-4B6F-4023-B4A7-C042107240F8Q34993103-E75599DC-78D8-4BCF-BBE4-255C89166E8BQ35011997-E7459F31-249C-4CDD-8CD7-DE6995C75C33Q35040590-2A556908-1180-4716-AC77-9C8C112BA0C7Q35131228-AD942BFE-55DC-403C-8485-8AC9BE53D72DQ35177355-D6C70571-68D9-4A95-ABC2-4F7DE712BC90Q35230705-18F2F688-4539-4571-AD9A-5FF63AD5E7E5Q35346318-67F4B5E9-89DA-4545-B816-2D2CA4D39214Q35440924-42E1C59D-F73C-4012-84B9-08AE979D0BA1Q35526694-F7CB66DE-0036-459F-A037-CD9D869D0068Q35568407-DBC76834-C403-4BFA-A3C0-A28E25AD4D4BQ35639872-1D4E7BD4-773D-434E-8080-2D33DF870DA7Q35736120-5D60E0FE-79DA-4C13-BBE3-F1943459DF4EQ35799636-FB58A6C9-4C8A-434D-961B-007E435723D5Q35841016-1B0E3836-05EC-44ED-A1FB-E3CB57ABA1A9Q36002565-2DC06F4D-C837-4655-AE17-3F3A425E77AFQ36084249-E2740EAA-5E57-4309-9D6E-7E424B2431BD
P2860
HIV disease progression: depression, stress, and possible mechanisms.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
HIV disease progression: depression, stress, and possible mechanisms.
@ast
HIV disease progression: depression, stress, and possible mechanisms.
@en
type
label
HIV disease progression: depression, stress, and possible mechanisms.
@ast
HIV disease progression: depression, stress, and possible mechanisms.
@en
prefLabel
HIV disease progression: depression, stress, and possible mechanisms.
@ast
HIV disease progression: depression, stress, and possible mechanisms.
@en
P1476
HIV disease progression: depression, stress, and possible mechanisms.
@en
P2093
Jane Leserman
P304
P356
10.1016/S0006-3223(03)00323-8
P407
P577
2003-08-01T00:00:00Z